Joan T Merrill Selected Research

Hydroxychloroquine (Plaquenil)

12/2023	Association Between Severe Nonadherence to Hydroxychloroquine and Systemic Lupus Erythematosus Flares, Damage, and Mortality in 660 Patients From the SLICC Inception Cohort.
1/2022	Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joan T Merrill Research Topics

Disease

95	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2024 - 07/2002
21	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 10/2020 - 03/2003
18	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 12/2004
11	Lupus Nephritis 01/2023 - 11/2005
10	Infections 07/2023 - 10/2012
10	Thrombosis (Thrombus) 01/2021 - 03/2003
7	Inflammation (Inflammations) 01/2021 - 01/2010
6	Atherosclerosis 03/2010 - 09/2002
5	Rheumatoid Arthritis 01/2018 - 04/2006
4	Human Influenza (Influenza) 04/2024 - 08/2011
4	Exanthema (Rash) 01/2023 - 10/2011
4	Neoplasms (Cancer) 12/2021 - 06/2003
4	Nephritis 06/2017 - 04/2009
3	Arthritis (Polyarthritis) 01/2022 - 01/2018
3	Hypertension (High Blood Pressure) 01/2019 - 09/2015
3	Proteinuria 01/2018 - 02/2014
3	Herpes Zoster 01/2017 - 02/2014
3	Venous Thrombosis (Deep-Vein Thrombosis) 12/2005 - 01/2004
2	Acne Vulgaris 01/2023 - 09/2004
2	Headache (Headaches) 12/2021 - 11/2013
2	COVID-19 01/2021 - 10/2020
2	Pre-Eclampsia (Preeclampsia) 01/2019 - 10/2003
2	Stroke (Strokes) 10/2018 - 06/2006
2	Chronic Kidney Failure (Chronic Renal Failure) 12/2017 - 05/2009
2	Neurologic Manifestations (Neurological Manifestations) 01/2016 - 04/2006
2	Genetic Predisposition to Disease (Genetic Predisposition) 12/2015 - 01/2013
2	Thrombotic Thrombocytopenic Purpura 01/2015 - 04/2008
2	malar rash 01/2015 - 10/2011
2	Alzheimer Disease (Alzheimer's Disease) 11/2005 - 06/2003
1	Ataxia (Dyssynergia) 04/2024
1	Cranial Nerve Diseases (Cranial Nerve Disorders) 04/2024
1	Chronic Disease (Chronic Diseases) 01/2023
1	Seizures (Absence Seizure) 01/2023
1	Fatigue 01/2023
1	Neutropenia 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022
1	Skin Neoplasms (Skin Cancer) 12/2021
1	Breast Neoplasms (Breast Cancer) 12/2021
1	Rheumatic Diseases (Rheumatism) 01/2021

Drug/Important Bio-Agent (IBA)

21	AutoantibodiesIBA 04/2024 - 06/2003
13	AntibodiesIBA 04/2024 - 10/2003
11	InterferonsIBA 01/2022 - 11/2011
10	Antiphospholipid AntibodiesIBA 01/2023 - 01/2004
10	belimumabIBA 11/2022 - 01/2008
10	Monoclonal AntibodiesIBA 11/2022 - 12/2002
9	Biomarkers (Surrogate Marker)IBA 01/2020 - 08/2008
8	B-Cell Activating FactorIBA 12/2023 - 01/2008
8	Antinuclear AntibodiesIBA 01/2022 - 04/2006
7	Proteins (Proteins, Gene)FDA Link 04/2024 - 10/2003
7	Estrogens (Estrogen)FDA Link 01/2018 - 06/2005
6	Immunoglobulin G (IgG)IBA 01/2021 - 03/2003
6	Interferon Type IIBA 01/2018 - 01/2010
5	GlucocorticoidsIBA 12/2023 - 02/2014
5	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 04/2009
5	anifrolumabIBA 01/2022 - 01/2017
5	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 10/2018 - 06/2005
5	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2016 - 10/2003
4	LigandsIBA 12/2023 - 06/2003
4	Prednisone (Sone)FDA LinkGeneric 12/2023 - 07/2002
4	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2021 - 07/2002
4	Complement System Proteins (Complement)IBA 10/2020 - 01/2013
4	SteroidsIBA 01/2018 - 07/2002
4	Dehydroepiandrosterone (DHEA)IBA 11/2005 - 07/2002
3	Immunosuppressive Agents (Immunosuppressants)IBA 01/2023 - 12/2021
3	TACI receptor-IgG Fc fragment fusion proteinIBA 11/2021 - 08/2008
3	CytokinesIBA 12/2014 - 01/2013
3	interleukin-21 (interleukin 21)IBA 10/2011 - 08/2009
3	CholesterolIBA 03/2010 - 09/2002
3	beta 2-Glycoprotein I (Apolipoprotein H)IBA 04/2008 - 06/2003
3	Anticardiolipin AntibodiesIBA 12/2005 - 03/2003
2	AntigensIBA 04/2024 - 10/2016
2	VaccinesIBA 04/2024 - 01/2021
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2023 - 01/2022
2	iberdomideIBA 04/2022 - 01/2022
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 12/2014
2	Antimalarials (Antimalarial Agents)IBA 12/2021 - 11/2013
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021 - 11/2005
2	Antirheumatic Agents (DMARD)IBA 01/2018 - 11/2014
2	AMG623 peptibodyIBA 01/2018 - 08/2015
2	tocilizumab (atlizumab)FDA Link 01/2018 - 11/2014
2	CreatinineIBA 06/2017 - 02/2014
2	sifalimumabIBA 11/2016 - 11/2011
2	Prostaglandins AIBA 01/2016 - 08/2015
2	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2013 - 04/2008
2	Endothelial Protein C ReceptorIBA 03/2012 - 05/2009
2	Interleukin-2 (IL2)IBA 09/2011 - 06/2011
2	Rituximab (Mabthera)FDA Link 01/2010 - 10/2003
2	Protein SIBA 01/2010 - 10/2003
2	CD11b AntigenIBA 03/2009 - 02/2008
2	LipidsIBA 06/2003 - 09/2002
1	KinesinsIBA 04/2024
1	telitaciceptIBA 12/2023
1	Antigen Receptors (Antigen Receptor)IBA 07/2023
1	deucravacitinibIBA 01/2023
1	TYK2 Kinase (Tyrosine Kinase 2)IBA 01/2023
1	Platelet Factor 4IBA 01/2021
1	Thromboplastin (Tissue Factor)IBA 01/2021
1	FibrinIBA 01/2021

Therapy/Procedure

17	Therapeutics 05/2024 - 09/2004
1	Drug Tapering 12/2023